Clal Biotechnology reported ILS86.82M in Pre-Tax Profit for its fiscal quarter ending in December of 2022.


Pre Tax Profit Change Date
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -7360000 1.25M Jun/2025
Life Technologies USD -19530000 4.56M Jun/2025
RedHill Biopharma USD -1540000 12M Jun/2024